Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("LEVIS, Mark J")

Results 1 to 10 of 10

  • Page / 1
Export

Selection :

  • and

FLT3 inhibitors for acute myeloid leukemia: a review of their efficacy and mechanisms of resistance : Efficacy and resistance of molecularly targeted therapy for myeloid malignanciesGRUNWALD, Michael R; LEVIS, Mark J.International journal of hematology. 2013, Vol 97, Num 6, pp 683-694, issn 0925-5710, 12 p.Article

Randomized phase II study of two schedules of flavopiridol given as timed sequential therapy with cytosine arabinoside and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemiaKARP, Judith E; GARRETT-MAYER, Elizabeth; LEVIS, Mark J et al.Haematologica (Roma). 2012, Vol 97, Num 11, pp 1736-1742, issn 0390-6078, 7 p.Article

A phase 1 clinical-laboratory study of clofarabine followed by cyclophosphamide for adults with refractory acute leukemiasKARP, Judith E; RICKLIS, Rebecca M; GANDHI, Varsha et al.Blood. 2007, Vol 110, Num 6, pp 1762-1769, issn 0006-4971, 8 p.Article

A clinically relevant population of leukemic CD34+CD38- cells in acute myeloid leukemiaGERBER, Jonathan M; DOUGLAS SMITH, B; GRIFFIN, Constance A et al.Blood. 2012, Vol 119, Num 15, pp 3571-3577, issn 0006-4971, 7 p.Article

Phase I and Pharmacologic Trial of Cytosine Arabinoside with the Selective Checkpoint 1 Inhibitor Sch 900776 in Refractory Acute LeukemiasKARP, Judith E; THOMAS, Brian M; MACKEY, Karen et al.Clinical cancer research (Print). 2012, Vol 18, Num 24, pp 6723-6731, issn 1078-0432, 9 p.Article

Phase 1 and pharmacokinetic study of bolus-infusion flavopiridol followed by cytosine arabinoside and mitoxantrone for acute leukemiasKARP, Judith E; SMITH, B. Douglas; JOSEPH, Biju et al.Blood. 2011, Vol 117, Num 12, pp 3302-3310, issn 0006-4971, 9 p.Article

Multi-institutional phase 2 clinical and pharmacogenomic trial of tipifarnib plus etoposide for elderly adults with newly diagnosed acute myelogenous leukemiaKARP, Judith E; VENER, Tatiana I; CARRAWAY, Hetty E et al.Blood. 2012, Vol 119, Num 1, pp 55-63, issn 0006-4971, 9 p.Article

Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemiaSMITH, Catherine C; QI WANG; ZARRINKAR, Patrick P et al.Nature (London). 2012, Vol 485, Num 7397, pp 260-263, issn 0028-0836, 4 p.Article

New Lesions Detected by Single Nucleotide Polymorphism Array-Based Chromosomal Analysis Have Important Clinical Impact in Acute Myeloid LeukemiaTIU, Ramon V; GONDEK, Lukasz P; ADVANI, Anjali S et al.Journal of clinical oncology. 2009, Vol 27, Num 31, pp 5219-5226, issn 0732-183X, 8 p.Conference Paper

Sequential flavopiridol, cytosine arabinoside, and mitoxantrone : A phase II trial in adults with poor-risk acute myelogenous leukemiaKARP, Judith E; SMITH, B. Douglas; LEVIS, Mark J et al.Clinical cancer research. 2007, Vol 13, Num 15, pp 4467-4473, issn 1078-0432, 7 p., 1Article

  • Page / 1